1. Home
  2. MRVI vs MTRX Comparison

MRVI vs MTRX Comparison

Compare MRVI & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • MTRX
  • Stock Information
  • Founded
  • MRVI 2014
  • MTRX 1984
  • Country
  • MRVI United States
  • MTRX United States
  • Employees
  • MRVI N/A
  • MTRX N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • MTRX Engineering & Construction
  • Sector
  • MRVI Health Care
  • MTRX Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • MTRX Nasdaq
  • Market Cap
  • MRVI 376.2M
  • MTRX 375.0M
  • IPO Year
  • MRVI 2020
  • MTRX 1990
  • Fundamental
  • Price
  • MRVI $3.24
  • MTRX $14.57
  • Analyst Decision
  • MRVI Hold
  • MTRX Strong Buy
  • Analyst Count
  • MRVI 9
  • MTRX 1
  • Target Price
  • MRVI $4.54
  • MTRX $17.00
  • AVG Volume (30 Days)
  • MRVI 1.7M
  • MTRX 220.7K
  • Earning Date
  • MRVI 11-06-2025
  • MTRX 11-05-2025
  • Dividend Yield
  • MRVI N/A
  • MTRX N/A
  • EPS Growth
  • MRVI N/A
  • MTRX N/A
  • EPS
  • MRVI N/A
  • MTRX N/A
  • Revenue
  • MRVI $219,830,000.00
  • MTRX $769,286,000.00
  • Revenue This Year
  • MRVI N/A
  • MTRX $18.36
  • Revenue Next Year
  • MRVI $7.27
  • MTRX $8.56
  • P/E Ratio
  • MRVI N/A
  • MTRX N/A
  • Revenue Growth
  • MRVI N/A
  • MTRX 5.64
  • 52 Week Low
  • MRVI $1.67
  • MTRX $9.33
  • 52 Week High
  • MRVI $8.29
  • MTRX $16.11
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 50.18
  • MTRX 66.86
  • Support Level
  • MRVI $3.32
  • MTRX $12.74
  • Resistance Level
  • MRVI $3.55
  • MTRX $13.51
  • Average True Range (ATR)
  • MRVI 0.19
  • MTRX 0.41
  • MACD
  • MRVI -0.04
  • MTRX 0.23
  • Stochastic Oscillator
  • MRVI 8.82
  • MTRX 100.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

Share on Social Networks: